Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group

OS Nielsen, P Dombernowsky, H Mouridsen, S Daugaard, M Glabbeke, A Kirkpatrick, Jaap Verweij

Research output: Contribution to journalArticleAcademic

29 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)31-35
Number of pages5
JournalSarcoma
Volume4
Publication statusPublished - 2000

Research programs

  • EMC MM-03-86-08

Cite this